APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Swine Influenza Vaccines

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Swine Influenza Vaccines Market Analysis and Forecast 2026-2032

Report ID 174039000230 December 2025198 pages

Choose your research edition.

Industry ResearchSwine Influenza Vaccines Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Swine Influenza Vaccines Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Swine Influenza Vaccines Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Swine Influenza Vaccines Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Swine Influenza Vaccines Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Swine Influenza Vaccines market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Swine Influenza Vaccines is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Swine Influenza Vaccines is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Swine Influenza Vaccines is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Swine Influenza Vaccines is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Swine Influenza Vaccines include Boehringer Ingelheim, CAHIC, Ceva, DHN, Green Cross Veterinary, Hipra, MSD Animal Health (Merck), Ringpu Biology and Zoetis, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Swine Influenza Vaccines, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Swine Influenza Vaccines, also provides the sales of main regions and countries. Of the upcoming market potential for Swine Influenza Vaccines, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Swine Influenza Vaccines sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Swine Influenza Vaccines market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Swine Influenza Vaccines sales, projected growth trends, production technology, application and end-user industry.

Swine Influenza Vaccines Segment by Company

Boehringer Ingelheim

CAHIC

Ceva

DHN

Green Cross Veterinary

Hipra

MSD Animal Health (Merck)

Ringpu Biology

Zoetis

Chengdu TECBOND

Swine Influenza Vaccines Segment by Type

Live Vaccines

Killed Vaccines

Swine Influenza Vaccines Segment by Application

Commodity Pig

Breeding Pig

Swine Influenza Vaccines Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Swine Influenza Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Swine Influenza Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Swine Influenza Vaccines.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Swine Influenza Vaccines in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Swine Influenza Vaccines manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Swine Influenza Vaccines sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Swine Influenza Vaccines Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Live Vaccines Major Manufacturers Table 3. Killed Vaccines Major Manufacturers Table 4. Global Swine Influenza Vaccines Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Commodity Pig Major Manufacturers Table 6. Breeding Pig Major Manufacturers Table 7. Swine Influenza Vaccines Industry Trends Table 8. Swine Influenza Vaccines Industry Drivers Table 9. Swine Influenza Vaccines Industry Opportunities and Challenges Table 10. Swine Influenza Vaccines Industry Restraints Table 11. Global Swine Influenza Vaccines Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 12. Global Swine Influenza Vaccines Revenue by Region (2021-2026) & (US$ Million) Table 13. Global Swine Influenza Vaccines Revenue by Region (2027-2032) & (US$ Million) Table 14. Global Swine Influenza Vaccines Revenue Market Share by Region (2021-2026) Table 15. Global Swine Influenza Vaccines Revenue Market Share by Region (2027-2032) Table 16. Global Swine Influenza Vaccines Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (M Units) Table 17. Global Swine Influenza Vaccines Sales by Region (2021-2026) & (M Units) Table 18. Global Swine Influenza Vaccines Sales by Region (2027-2032) & (M Units) Table 19. Global Swine Influenza Vaccines Sales Market Share by Region (2021-2026) Table 20. Global Swine Influenza Vaccines Sales Market Share by Region (2027-2032) Table 21. Global Swine Influenza Vaccines Revenue by Manufacturers (US$ Million) & (2021-2026) Table 22. Global Swine Influenza Vaccines Revenue Market Share by Manufacturers (2021-2026) Table 23. Global Swine Influenza Vaccines Sales by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Swine Influenza Vaccines Sales Market Share by Manufacturers (2021-2026) Table 25. Global Swine Influenza Vaccines Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 26. Global Swine Influenza Vaccines Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 27. Global Swine Influenza Vaccines Key Manufacturers Manufacturing Sites & Headquarters Table 28. Global Swine Influenza Vaccines Manufacturers, Product Type & Application Table 29. Global Swine Influenza Vaccines Manufacturers' Establishment Date Table 30. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 31. Global Swine Influenza Vaccines by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 32. Global Swine Influenza Vaccines Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Swine Influenza Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 34. Global Swine Influenza Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 35. Global Swine Influenza Vaccines Revenue Market Share by Type (2021-2026) Table 36. Global Swine Influenza Vaccines Revenue Market Share by Type (2027-2032) Table 37. Global Swine Influenza Vaccines Sales by Type 2021 VS 2025 VS 2032 (M Units) Table 38. Global Swine Influenza Vaccines Sales by Type (2021-2026) & (M Units) Table 39. Global Swine Influenza Vaccines Sales by Type (2027-2032) & (M Units) Table 40. Global Swine Influenza Vaccines Sales Market Share by Type (2021-2026) Table 41. Global Swine Influenza Vaccines Sales Market Share by Type (2027-2032) Table 42. Global Swine Influenza Vaccines Price by Type (2021-2026) & (US$/Unit) Table 43. Global Swine Influenza Vaccines Price by Type (2027-2032) & (US$/Unit) Table 44. Global Swine Influenza Vaccines Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 45. Global Swine Influenza Vaccines Revenue by Application (2021-2026) & (US$ Million) Table 46. Global Swine Influenza Vaccines Revenue by Application (2027-2032) & (US$ Million) Table 47. Global Swine Influenza Vaccines Revenue Market Share by Application (2021-2026) Table 48. Global Swine Influenza Vaccines Revenue Market Share by Application (2027-2032) Table 49. Global Swine Influenza Vaccines Sales by Application 2021 VS 2025 VS 2032 (M Units) Table 50. Global Swine Influenza Vaccines Sales by Application (2021-2026) & (M Units) Table 51. Global Swine Influenza Vaccines Sales by Application (2027-2032) & (M Units) Table 52. Global Swine Influenza Vaccines Sales Market Share by Application (2021-2026) Table 53. Global Swine Influenza Vaccines Sales Market Share by Application (2027-2032) Table 54. Global Swine Influenza Vaccines Price by Application (2021-2026) & (US$/Unit) Table 55. Global Swine Influenza Vaccines Price by Application (2027-2032) & (US$/Unit) Table 56. Boehringer Ingelheim Company Information Table 57. Boehringer Ingelheim Business Overview Table 58. Boehringer Ingelheim Swine Influenza Vaccines Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 59. Boehringer Ingelheim Swine Influenza Vaccines Product Portfolio Table 60. Boehringer Ingelheim Recent Development Table 61. CAHIC Company Information Table 62. CAHIC Business Overview Table 63. CAHIC Swine Influenza Vaccines Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 64. CAHIC Swine Influenza Vaccines Product Portfolio Table 65. CAHIC Recent Development Table 66. Ceva Company Information Table 67. Ceva Business Overview Table 68. Ceva Swine Influenza Vaccines Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 69. Ceva Swine Influenza Vaccines Product Portfolio Table 70. Ceva Recent Development Table 71. DHN Company Information Table 72. DHN Business Overview Table 73. DHN Swine Influenza Vaccines Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. DHN Swine Influenza Vaccines Product Portfolio Table 75. DHN Recent Development Table 76. Green Cross Veterinary Company Information Table 77. Green Cross Veterinary Business Overview Table 78. Green Cross Veterinary Swine Influenza Vaccines Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Green Cross Veterinary Swine Influenza Vaccines Product Portfolio Table 80. Green Cross Veterinary Recent Development Table 81. Hipra Company Information Table 82. Hipra Business Overview Table 83. Hipra Swine Influenza Vaccines Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Hipra Swine Influenza Vaccines Product Portfolio Table 85. Hipra Recent Development Table 86. MSD Animal Health (Merck) Company Information Table 87. MSD Animal Health (Merck) Business Overview Table 88. MSD Animal Health (Merck) Swine Influenza Vaccines Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. MSD Animal Health (Merck) Swine Influenza Vaccines Product Portfolio Table 90. MSD Animal Health (Merck) Recent Development Table 91. Ringpu Biology Company Information Table 92. Ringpu Biology Business Overview Table 93. Ringpu Biology Swine Influenza Vaccines Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Ringpu Biology Swine Influenza Vaccines Product Portfolio Table 95. Ringpu Biology Recent Development Table 96. Zoetis Company Information Table 97. Zoetis Business Overview Table 98. Zoetis Swine Influenza Vaccines Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Zoetis Swine Influenza Vaccines Product Portfolio Table 100. Zoetis Recent Development Table 101. Chengdu TECBOND Company Information Table 102. Chengdu TECBOND Business Overview Table 103. Chengdu TECBOND Swine Influenza Vaccines Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. Chengdu TECBOND Swine Influenza Vaccines Product Portfolio Table 105. Chengdu TECBOND Recent Development Table 106. North America Swine Influenza Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 107. North America Swine Influenza Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 108. North America Swine Influenza Vaccines Sales by Type (2021-2026) & (M Units) Table 109. North America Swine Influenza Vaccines Sales by Type (2027-2032) & (M Units) Table 110. North America Swine Influenza Vaccines Sales Price by Type (2021-2026) & (US$/Unit) Table 111. North America Swine Influenza Vaccines Sales Price by Type (2027-2032) & (US$/Unit) Table 112. North America Swine Influenza Vaccines Revenue by Application (2021-2026) & (US$ Million) Table 113. North America Swine Influenza Vaccines Revenue by Application (2027-2032) & (US$ Million) Table 114. North America Swine Influenza Vaccines Sales by Application (2021-2026) & (M Units) Table 115. North America Swine Influenza Vaccines Sales by Application (2027-2032) & (M Units) Table 116. North America Swine Influenza Vaccines Sales Price by Application (2021-2026) & (US$/Unit) Table 117. North America Swine Influenza Vaccines Sales Price by Application (2027-2032) & (US$/Unit) Table 118. North America Swine Influenza Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 119. North America Swine Influenza Vaccines Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 120. North America Swine Influenza Vaccines Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 121. North America Swine Influenza Vaccines Sales by Country (2021 VS 2025 VS 2032) & (M Units) Table 122. North America Swine Influenza Vaccines Sales by Country (2021-2026) & (M Units) Table 123. North America Swine Influenza Vaccines Sales by Country (2027-2032) & (M Units) Table 124. North America Swine Influenza Vaccines Sales Price by Country (2021-2026) & (US$/Unit) Table 125. North America Swine Influenza Vaccines Sales Price by Country (2027-2032) & (US$/Unit) Table 126. United States Swine Influenza Vaccines Revenue (2021-2032) & (US$ Million) Table 127. Canada Swine Influenza Vaccines Revenue (2021-2032) & (US$ Million) Table 128. Europe Swine Influenza Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 129. Europe Swine Influenza Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 130. Europe Swine Influenza Vaccines Sales by Type (2021-2026) & (M Units) Table 131. Europe Swine Influenza Vaccines Sales by Type (2027-2032) & (M Units) Table 132. Europe Swine Influenza Vaccines Sales Price by Type (2021-2026) & (US$/Unit) Table 133. Europe Swine Influenza Vaccines Sales Price by Type (2027-2032) & (US$/Unit) Table 134. Europe Swine Influenza Vaccines Revenue by Application (2021-2026) & (US$ Million) Table 135. Europe Swine Influenza Vaccines Revenue by Application (2027-2032) & (US$ Million) Table 136. Europe Swine Influenza Vaccines Sales by Application (2021-2026) & (M Units) Table 137. Europe Swine Influenza Vaccines Sales by Application (2027-2032) & (M Units) Table 138. Europe Swine Influenza Vaccines Sales Price by Application (2021-2026) & (US$/Unit) Table 139. Europe Swine Influenza Vaccines Sales Price by Application (2027-2032) & (US$/Unit) Table 140. Europe Swine Influenza Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 141. Europe Swine Influenza Vaccines Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 142. Europe Swine Influenza Vaccines Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 143. Europe Swine Influenza Vaccines Sales by Country (2021 VS 2025 VS 2032) & (M Units) Table 144. Europe Swine Influenza Vaccines Sales by Country (2021-2026) & (M Units) Table 145. Europe Swine Influenza Vaccines Sales by Country (2027-2032) & (M Units) Table 146. Europe Swine Influenza Vaccines Sales Price by Country (2021-2026) & (US$/Unit) Table 147. Europe Swine Influenza Vaccines Sales Price by Country (2027-2032) & (US$/Unit) Table 148. Germany Swine Influenza Vaccines Revenue (2021-2032) & (US$ Million) Table 149. France Swine Influenza Vaccines Revenue (2021-2032) & (US$ Million) Table 150. U.K. Swine Influenza Vaccines Revenue (2021-2032) & (US$ Million) Table 151. Italy Swine Influenza Vaccines Revenue (2021-2032) & (US$ Million) Table 152. Netherlands Swine Influenza Vaccines Revenue (2021-2032) & (US$ Million) Table 153. China Swine Influenza Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 154. China Swine Influenza Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 155. China Swine Influenza Vaccines Sales by Type (2021-2026) & (M Units) Table 156. China Swine Influenza Vaccines Sales by Type (2027-2032) & (M Units) Table 157. China Swine Influenza Vaccines Sales Price by Type (2021-2026) & (US$/Unit) Table 158. China Swine Influenza Vaccines Sales Price by Type (2027-2032) & (US$/Unit) Table 159. China Swine Influenza Vaccines Revenue by Application (2021-2026) & (US$ Million) Table 160. China Swine Influenza Vaccines Revenue by Application (2027-2032) & (US$ Million) Table 161. China Swine Influenza Vaccines Sales by Application (2021-2026) & (M Units) Table 162. China Swine Influenza Vaccines Sales by Application (2027-2032) & (M Units) Table 163. China Swine Influenza Vaccines Sales Price by Application (2021-2026) & (US$/Unit) Table 164. China Swine Influenza Vaccines Sales Price by Application (2027-2032) & (US$/Unit) Table 165. Asia Swine Influenza Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 166. Asia Swine Influenza Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 167. Asia Swine Influenza Vaccines Sales by Type (2021-2026) & (M Units) Table 168. Asia Swine Influenza Vaccines Sales by Type (2027-2032) & (M Units) Table 169. Asia Swine Influenza Vaccines Sales Price by Type (2021-2026) & (US$/Unit) Table 170. Asia Swine Influenza Vaccines Sales Price by Type (2027-2032) & (US$/Unit) Table 171. Asia Swine Influenza Vaccines Revenue by Application (2021-2026) & (US$ Million) Table 172. Asia Swine Influenza Vaccines Revenue by Application (2027-2032) & (US$ Million) Table 173. Asia Swine Influenza Vaccines Sales by Application (2021-2026) & (M Units) Table 174. Asia Swine Influenza Vaccines Sales by Application (2027-2032) & (M Units) Table 175. Asia Swine Influenza Vaccines Sales Price by Application (2021-2026) & (US$/Unit) Table 176. Asia Swine Influenza Vaccines Sales Price by Application (2027-2032) & (US$/Unit) Table 177. Asia Swine Influenza Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 178. Asia Swine Influenza Vaccines Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 179. Asia Swine Influenza Vaccines Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 180. Asia Swine Influenza Vaccines Sales by Country (2021 VS 2025 VS 2032) & (M Units) Table 181. Asia Swine Influenza Vaccines Sales by Country (2021-2026) & (M Units) Table 182. Asia Swine Influenza Vaccines Sales by Country (2027-2032) & (M Units) Table 183. Asia Swine Influenza Vaccines Sales Price by Country (2021-2026) & (US$/Unit) Table 184. Asia Swine Influenza Vaccines Sales Price by Country (2027-2032) & (US$/Unit) Table 185. Japan Swine Influenza Vaccines Revenue (2021-2032) & (US$ Million) Table 186. South Korea Swine Influenza Vaccines Revenue (2021-2032) & (US$ Million) Table 187. India Swine Influenza Vaccines Revenue (2021-2032) & (US$ Million) Table 188. Australia Swine Influenza Vaccines Revenue (2021-2032) & (US$ Million) Table 189. China Taiwan Swine Influenza Vaccines Revenue (2021-2032) & (US$ Million) Table 190. Southeast Asia Swine Influenza Vaccines Revenue (2021-2032) & (US$ Million) Table 191. SAMEA Swine Influenza Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 192. SAMEA Swine Influenza Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 193. SAMEA Swine Influenza Vaccines Sales by Type (2021-2026) & (M Units) Table 194. SAMEA Swine Influenza Vaccines Sales by Type (2027-2032) & (M Units) Table 195. SAMEA Swine Influenza Vaccines Sales Price by Type (2021-2026) & (US$/Unit) Table 196. SAMEA Swine Influenza Vaccines Sales Price by Type (2027-2032) & (US$/Unit) Table 197. SAMEA Swine Influenza Vaccines Revenue by Application (2021-2026) & (US$ Million) Table 198. SAMEA Swine Influenza Vaccines Revenue by Application (2027-2032) & (US$ Million) Table 199. SAMEA Swine Influenza Vaccines Sales by Application (2021-2026) & (M Units) Table 200. SAMEA Swine Influenza Vaccines Sales by Application (2027-2032) & (M Units) Table 201. SAMEA Swine Influenza Vaccines Sales Price by Application (2021-2026) & (US$/Unit) Table 202. SAMEA Swine Influenza Vaccines Sales Price by Application (2027-2032) & (US$/Unit) Table 203. SAMEA Swine Influenza Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 204. SAMEA Swine Influenza Vaccines Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 205. SAMEA Swine Influenza Vaccines Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 206. SAMEA Swine Influenza Vaccines Sales by Country (2021 VS 2025 VS 2032) & (M Units) Table 207. SAMEA Swine Influenza Vaccines Sales by Country (2021-2026) & (M Units) Table 208. SAMEA Swine Influenza Vaccines Sales by Country (2027-2032) & (M Units) Table 209. SAMEA Swine Influenza Vaccines Sales Price by Country (2021-2026) & (US$/Unit) Table 210. SAMEA Swine Influenza Vaccines Sales Price by Country (2027-2032) & (US$/Unit) Table 211. Brazil Swine Influenza Vaccines Revenue (2021-2032) & (US$ Million) Table 212. Argentina Swine Influenza Vaccines Revenue (2021-2032) & (US$ Million) Table 213. Chile Swine Influenza Vaccines Revenue (2021-2032) & (US$ Million) Table 214. Colombia Swine Influenza Vaccines Revenue (2021-2032) & (US$ Million) Table 215. Peru Swine Influenza Vaccines Revenue (2021-2032) & (US$ Million) Table 216. Saudi Arabia Swine Influenza Vaccines Revenue (2021-2032) & (US$ Million) Table 217. Israel Swine Influenza Vaccines Revenue (2021-2032) & (US$ Million) Table 218. UAE Swine Influenza Vaccines Revenue (2021-2032) & (US$ Million) Table 219. Turkey Swine Influenza Vaccines Revenue (2021-2032) & (US$ Million) Table 220. Iran Swine Influenza Vaccines Revenue (2021-2032) & (US$ Million) Table 221. Egypt Swine Influenza Vaccines Revenue (2021-2032) & (US$ Million) Table 222. Key Raw Materials Table 223. Raw Materials Key Suppliers Table 224. Swine Influenza Vaccines Distributors List Table 225. Swine Influenza Vaccines Customers List Table 226. Research Programs/Design for This Report Table 227. Authors List of This Report Table 228. Secondary Sources Table 229. Primary Sources List of Figures Figure 1. Swine Influenza Vaccines Image Figure 2. Global Swine Influenza Vaccines Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Swine Influenza Vaccines Market Size Share 2021 VS 2025 VS 2032 Figure 4. Live Vaccines Image Figure 5. Killed Vaccines Image Figure 6. Global Swine Influenza Vaccines Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Swine Influenza Vaccines Market Size Share 2021 VS 2025 VS 2032 Figure 8. Commodity Pig Image Figure 9. Breeding Pig Image Figure 10. Global Swine Influenza Vaccines Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 11. Global Swine Influenza Vaccines Revenue (2021-2032) & (US$ Million) Figure 12. Global Swine Influenza Vaccines Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 13. Global Swine Influenza Vaccines Revenue Market Share by Region: 2025 Versus 2032 Figure 14. Global Swine Influenza Vaccines Revenue Market Share by Region (2021-2032) Figure 15. Global Swine Influenza Vaccines Sales (2021-2032) & (M Units) Figure 16. Global Swine Influenza Vaccines Sales by Region: 2021 VS 2025 VS 2032 (M Units) Figure 17. Global Swine Influenza Vaccines Sales Market Share by Region (2021-2032) Figure 18. US & Canada & Mexico Swine Influenza Vaccines Sales YoY (2021-2032) & (M Units) Figure 19. Europe Swine Influenza Vaccines Sales YoY (2021-2032) & (M Units) Figure 20. China Swine Influenza Vaccines Sales YoY (2021-2032) & (M Units) Figure 21. Asia (Excluding China) Swine Influenza Vaccines Sales YoY (2021-2032) & (M Units) Figure 22. South America, Middle East and Africa Swine Influenza Vaccines Sales YoY (2021-2032) & (M Units) Figure 23. Global Swine Influenza Vaccines Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 24. Global Swine Influenza Vaccines Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 25. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 26. Global Swine Influenza Vaccines Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 27. Global Swine Influenza Vaccines Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 28. Global Swine Influenza Vaccines Revenue Market Share by Type (2021-2032) Figure 29. Global Swine Influenza Vaccines Sales by Type (2021 VS 2025 VS 2032) & (M Units) Figure 30. Global Swine Influenza Vaccines Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 31. Global Swine Influenza Vaccines Sales Market Share by Type (2021-2032) Figure 32. Global Swine Influenza Vaccines Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 33. Global Swine Influenza Vaccines Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 34. Global Swine Influenza Vaccines Revenue Market Share by Application (2021-2032) Figure 35. Global Swine Influenza Vaccines Sales by Application (2021 VS 2025 VS 2032) & (M Units) Figure 36. Global Swine Influenza Vaccines Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 37. Global Swine Influenza Vaccines Sales Market Share by Application (2021-2032) Figure 38. North America Swine Influenza Vaccines Revenue Share by Type (2021-2032) Figure 39. North America Swine Influenza Vaccines Sales Share by Type (2021-2032) Figure 40. North America Swine Influenza Vaccines Revenue Share by Application (2021-2032) Figure 41. North America Swine Influenza Vaccines Sales Share by Application (2021-2032) Figure 42. North America Swine Influenza Vaccines Revenue Share by Country (2021-2032) Figure 43. North America Swine Influenza Vaccines Sales Share by Country (2021-2032) Figure 44. Europe Swine Influenza Vaccines Revenue Share by Type (2021-2032) Figure 45. Europe Swine Influenza Vaccines Sales Share by Type (2021-2032) Figure 46. Europe Swine Influenza Vaccines Revenue Share by Application (2021-2032) Figure 47. Europe Swine Influenza Vaccines Sales Share by Application (2021-2032) Figure 48. Europe Swine Influenza Vaccines Revenue Share by Country (2021-2032) Figure 49. Europe Swine Influenza Vaccines Sales Share by Country (2021-2032) Figure 50. China Swine Influenza Vaccines Revenue Share by Type (2021-2032) Figure 51. China Swine Influenza Vaccines Sales Share by Type (2021-2032) Figure 52. China Swine Influenza Vaccines Revenue Share by Application (2021-2032) Figure 53. China Swine Influenza Vaccines Sales Share by Application (2021-2032) Figure 54. Asia Swine Influenza Vaccines Revenue Share by Type (2021-2032) Figure 55. Asia Swine Influenza Vaccines Sales Share by Type (2021-2032) Figure 56. Asia Swine Influenza Vaccines Revenue Share by Application (2021-2032) Figure 57. Asia Swine Influenza Vaccines Sales Share by Application (2021-2032) Figure 58. Asia Swine Influenza Vaccines Revenue Share by Country (2021-2032) Figure 59. Asia Swine Influenza Vaccines Sales Share by Country (2021-2032) Figure 60. SAMEA Swine Influenza Vaccines Revenue Share by Type (2021-2032) Figure 61. SAMEA Swine Influenza Vaccines Sales Share by Type (2021-2032) Figure 62. SAMEA Swine Influenza Vaccines Revenue Share by Application (2021-2032) Figure 63. SAMEA Swine Influenza Vaccines Sales Share by Application (2021-2032) Figure 64. SAMEA Swine Influenza Vaccines Revenue Share by Country (2021-2032) Figure 65. SAMEA Swine Influenza Vaccines Sales Share by Country (2021-2032) Figure 66. Swine Influenza Vaccines Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Swine Influenza Vaccines Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Live Vaccines
  • Killed Vaccines
Applications
  • Commodity Pig
  • Breeding Pig
Companies covered
  • Boehringer Ingelheim
  • CAHIC
  • Ceva
  • DHN
  • Green Cross Veterinary
  • Hipra
  • MSD Animal Health (Merck)
  • Ringpu Biology
  • Zoetis
  • Chengdu TECBOND

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Swine Influenza Vaccines Market by Type
  3. 1.2.1 Global Swine Influenza Vaccines Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Live Vaccines
  5. 1.2.3 Killed Vaccines
  6. 1.3 Swine Influenza Vaccines Market by Application
  7. 1.3.1 Global Swine Influenza Vaccines Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Commodity Pig
  9. 1.3.3 Breeding Pig
  10. 1.4 Assumptions and Limitations
  11. 1.5 Study Goals and Objectives
2 Swine Influenza Vaccines Market Dynamics
  1. 2.1 Swine Influenza Vaccines Industry Trends
  2. 2.2 Swine Influenza Vaccines Industry Drivers
  3. 2.3 Swine Influenza Vaccines Industry Opportunities and Challenges
  4. 2.4 Swine Influenza Vaccines Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Swine Influenza Vaccines Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Swine Influenza Vaccines Revenue by Region
  3. 3.2.1 Global Swine Influenza Vaccines Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Swine Influenza Vaccines Revenue by Region (2021-2026)
  5. 3.2.3 Global Swine Influenza Vaccines Revenue by Region (2027-2032)
  6. 3.2.4 Global Swine Influenza Vaccines Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Swine Influenza Vaccines Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Swine Influenza Vaccines Sales by Region
  9. 3.4.1 Global Swine Influenza Vaccines Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Swine Influenza Vaccines Sales by Region (2021-2026)
  11. 3.4.3 Global Swine Influenza Vaccines Sales by Region (2027-2032)
  12. 3.4.4 Global Swine Influenza Vaccines Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Swine Influenza Vaccines Revenue by Manufacturers
  2. 4.1.1 Global Swine Influenza Vaccines Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Swine Influenza Vaccines Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Swine Influenza Vaccines Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Swine Influenza Vaccines Sales by Manufacturers
  6. 4.2.1 Global Swine Influenza Vaccines Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Swine Influenza Vaccines Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Swine Influenza Vaccines Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Swine Influenza Vaccines Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Swine Influenza Vaccines Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Swine Influenza Vaccines Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Swine Influenza Vaccines Manufacturers, Product Type & Application
  13. 4.7 Global Swine Influenza Vaccines Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Swine Influenza Vaccines Market CR5 and HHI
  16. 4.8.2 2025 Swine Influenza Vaccines Tier 1, Tier 2, and Tier 3
5 Swine Influenza Vaccines Market by Type
  1. 5.1 Global Swine Influenza Vaccines Revenue by Type
  2. 5.1.1 Global Swine Influenza Vaccines Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Swine Influenza Vaccines Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Swine Influenza Vaccines Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Swine Influenza Vaccines Sales by Type
  6. 5.2.1 Global Swine Influenza Vaccines Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Swine Influenza Vaccines Sales by Type (2021-2032) & (M Units)
  8. 5.2.3 Global Swine Influenza Vaccines Sales Market Share by Type (2021-2032)
  9. 5.3 Global Swine Influenza Vaccines Price by Type
6 Swine Influenza Vaccines Market by Application
  1. 6.1 Global Swine Influenza Vaccines Revenue by Application
  2. 6.1.1 Global Swine Influenza Vaccines Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Swine Influenza Vaccines Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Swine Influenza Vaccines Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Swine Influenza Vaccines Sales by Application
  6. 6.2.1 Global Swine Influenza Vaccines Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Swine Influenza Vaccines Sales by Application (2021-2032) & (M Units)
  8. 6.2.3 Global Swine Influenza Vaccines Sales Market Share by Application (2021-2032)
  9. 6.3 Global Swine Influenza Vaccines Price by Application
7 Company Profiles
  1. 7.1 Boehringer Ingelheim
  2. 7.1.1 Boehringer Ingelheim Company Information
  3. 7.1.2 Boehringer Ingelheim Business Overview
  4. 7.1.3 Boehringer Ingelheim Swine Influenza Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Boehringer Ingelheim Swine Influenza Vaccines Product Portfolio
  6. 7.1.5 Boehringer Ingelheim Recent Developments
  7. 7.2 CAHIC
  8. 7.2.1 CAHIC Company Information
  9. 7.2.2 CAHIC Business Overview
  10. 7.2.3 CAHIC Swine Influenza Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 CAHIC Swine Influenza Vaccines Product Portfolio
  12. 7.2.5 CAHIC Recent Developments
  13. 7.3 Ceva
  14. 7.3.1 Ceva Company Information
  15. 7.3.2 Ceva Business Overview
  16. 7.3.3 Ceva Swine Influenza Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Ceva Swine Influenza Vaccines Product Portfolio
  18. 7.3.5 Ceva Recent Developments
  19. 7.4 DHN
  20. 7.4.1 DHN Company Information
  21. 7.4.2 DHN Business Overview
  22. 7.4.3 DHN Swine Influenza Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 DHN Swine Influenza Vaccines Product Portfolio
  24. 7.4.5 DHN Recent Developments
  25. 7.5 Green Cross Veterinary
  26. 7.5.1 Green Cross Veterinary Company Information
  27. 7.5.2 Green Cross Veterinary Business Overview
  28. 7.5.3 Green Cross Veterinary Swine Influenza Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Green Cross Veterinary Swine Influenza Vaccines Product Portfolio
  30. 7.5.5 Green Cross Veterinary Recent Developments
  31. 7.6 Hipra
  32. 7.6.1 Hipra Company Information
  33. 7.6.2 Hipra Business Overview
  34. 7.6.3 Hipra Swine Influenza Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Hipra Swine Influenza Vaccines Product Portfolio
  36. 7.6.5 Hipra Recent Developments
  37. 7.7 MSD Animal Health (Merck)
  38. 7.7.1 MSD Animal Health (Merck) Company Information
  39. 7.7.2 MSD Animal Health (Merck) Business Overview
  40. 7.7.3 MSD Animal Health (Merck) Swine Influenza Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 MSD Animal Health (Merck) Swine Influenza Vaccines Product Portfolio
  42. 7.7.5 MSD Animal Health (Merck) Recent Developments
  43. 7.8 Ringpu Biology
  44. 7.8.1 Ringpu Biology Company Information
  45. 7.8.2 Ringpu Biology Business Overview
  46. 7.8.3 Ringpu Biology Swine Influenza Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Ringpu Biology Swine Influenza Vaccines Product Portfolio
  48. 7.8.5 Ringpu Biology Recent Developments
  49. 7.9 Zoetis
  50. 7.9.1 Zoetis Company Information
  51. 7.9.2 Zoetis Business Overview
  52. 7.9.3 Zoetis Swine Influenza Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Zoetis Swine Influenza Vaccines Product Portfolio
  54. 7.9.5 Zoetis Recent Developments
  55. 7.10 Chengdu TECBOND
  56. 7.10.1 Chengdu TECBOND Company Information
  57. 7.10.2 Chengdu TECBOND Business Overview
  58. 7.10.3 Chengdu TECBOND Swine Influenza Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Chengdu TECBOND Swine Influenza Vaccines Product Portfolio
  60. 7.10.5 Chengdu TECBOND Recent Developments
8 North America
  1. 8.1 North America Swine Influenza Vaccines Market Size by Type
  2. 8.1.1 North America Swine Influenza Vaccines Revenue by Type (2021-2032)
  3. 8.1.2 North America Swine Influenza Vaccines Sales by Type (2021-2032)
  4. 8.1.3 North America Swine Influenza Vaccines Price by Type (2021-2032)
  5. 8.2 North America Swine Influenza Vaccines Market Size by Application
  6. 8.2.1 North America Swine Influenza Vaccines Revenue by Application (2021-2032)
  7. 8.2.2 North America Swine Influenza Vaccines Sales by Application (2021-2032)
  8. 8.2.3 North America Swine Influenza Vaccines Price by Application (2021-2032)
  9. 8.3 North America Swine Influenza Vaccines Market Size by Country
  10. 8.3.1 North America Swine Influenza Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Swine Influenza Vaccines Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Swine Influenza Vaccines Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe Swine Influenza Vaccines Market Size by Type
  2. 9.1.1 Europe Swine Influenza Vaccines Revenue by Type (2021-2032)
  3. 9.1.2 Europe Swine Influenza Vaccines Sales by Type (2021-2032)
  4. 9.1.3 Europe Swine Influenza Vaccines Price by Type (2021-2032)
  5. 9.2 Europe Swine Influenza Vaccines Market Size by Application
  6. 9.2.1 Europe Swine Influenza Vaccines Revenue by Application (2021-2032)
  7. 9.2.2 Europe Swine Influenza Vaccines Sales by Application (2021-2032)
  8. 9.2.3 Europe Swine Influenza Vaccines Price by Application (2021-2032)
  9. 9.3 Europe Swine Influenza Vaccines Market Size by Country
  10. 9.3.1 Europe Swine Influenza Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Swine Influenza Vaccines Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Swine Influenza Vaccines Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
10 China
  1. 10.1 China Swine Influenza Vaccines Market Size by Type
  2. 10.1.1 China Swine Influenza Vaccines Revenue by Type (2021-2032)
  3. 10.1.2 China Swine Influenza Vaccines Sales by Type (2021-2032)
  4. 10.1.3 China Swine Influenza Vaccines Price by Type (2021-2032)
  5. 10.2 China Swine Influenza Vaccines Market Size by Application
  6. 10.2.1 China Swine Influenza Vaccines Revenue by Application (2021-2032)
  7. 10.2.2 China Swine Influenza Vaccines Sales by Application (2021-2032)
  8. 10.2.3 China Swine Influenza Vaccines Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Swine Influenza Vaccines Market Size by Type
  2. 11.1.1 Asia Swine Influenza Vaccines Revenue by Type (2021-2032)
  3. 11.1.2 Asia Swine Influenza Vaccines Sales by Type (2021-2032)
  4. 11.1.3 Asia Swine Influenza Vaccines Price by Type (2021-2032)
  5. 11.2 Asia Swine Influenza Vaccines Market Size by Application
  6. 11.2.1 Asia Swine Influenza Vaccines Revenue by Application (2021-2032)
  7. 11.2.2 Asia Swine Influenza Vaccines Sales by Application (2021-2032)
  8. 11.2.3 Asia Swine Influenza Vaccines Price by Application (2021-2032)
  9. 11.3 Asia Swine Influenza Vaccines Market Size by Country
  10. 11.3.1 Asia Swine Influenza Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Swine Influenza Vaccines Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Swine Influenza Vaccines Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Swine Influenza Vaccines Market Size by Type
  2. 12.1.1 SAMEA Swine Influenza Vaccines Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Swine Influenza Vaccines Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Swine Influenza Vaccines Price by Type (2021-2032)
  5. 12.2 SAMEA Swine Influenza Vaccines Market Size by Application
  6. 12.2.1 SAMEA Swine Influenza Vaccines Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Swine Influenza Vaccines Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Swine Influenza Vaccines Price by Application (2021-2032)
  9. 12.3 SAMEA Swine Influenza Vaccines Market Size by Country
  10. 12.3.1 SAMEA Swine Influenza Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Swine Influenza Vaccines Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Swine Influenza Vaccines Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Swine Influenza Vaccines Value Chain Analysis
  2. 13.1.1 Swine Influenza Vaccines Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Swine Influenza Vaccines Production Mode & Process
  6. 13.2 Swine Influenza Vaccines Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Swine Influenza Vaccines Distributors
  9. 13.2.3 Swine Influenza Vaccines Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst